RIGL — RIGEL PHARMACEUTICALS INC
As of Q2 2026, 31 SEC-registered investment managers reported holding RIGL (RIGEL PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $218.56M across 5.60M shares. That is -14.0% by share count (-912.76K shares) versus the previous quarter, while reported value moved +24.3%. Ownership is concentrated: the five largest holders account for 63.7% of reported value and the top ten for 78.8%.
Compared with the prior quarter, 1 opened new positions, 16 added to existing stakes, 13 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
RIGL is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 1.94M | $75.89M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 1.04M | $44.48M | 0.00% | Hold |
| D. E. Shaw & Co history | Q2 2026 | 542.54K | $21.22M | 0.01% | Add |
| Geode Capital Management history | Q2 2026 | 483.18K | $18.91M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 367.39K | $14.37M | 0.01% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 226.78K | $8.87M | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 207.58K | $8.12M | 0.01% | Reduce |
| Morgan Stanley history | Q2 2026 | 186.05K | $7.28M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 154.63K | $6.05M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 146.38K | $5.73M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 145.85K | $5.71M | 0.01% | Reduce |
| AQR Capital Management history | Q2 2026 | 124.80K | $4.88M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 123.51K | $4.83M | 0.00% | Reduce |
| Franklin Resources history | Q2 2026 | 123.36K | $4.83M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 122.95K | $4.81M | 0.00% | Add |
| Arrowstreet Capital history | Q1 2026 | 167.34K | $4.52M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 108.21K | $4.23M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 96.11K | $3.76M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 135.88K | $3.67M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 93.69K | $3.67M | 0.00% | Reduce |
New Positions (Q2 2026)
- JPMorgan Chase & Co 41.67K sh · $1.63M
Fully Exited (vs previous quarter)
- Arrowstreet Capital sold 167.34K sh · $4.52M
- Janus Henderson Group sold 135.88K sh · $3.67M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | 1.56M | 1.75M | 1.73M | 1.63M | 1.72M | 1.66M | 1.77M | 1.94M |
| D. E. Shaw & Co | — | — | — | — | — | — | — | — | — | — | 306.49K | 424.32K | 445.68K | 542.54K |
| Geode Capital Management | — | — | — | — | — | 390.78K | 399.66K | 402.05K | 411.17K | 415.61K | 423.72K | 424.31K | 440.63K | 483.18K |
| Marshall Wace | — | — | — | — | — | — | — | — | 211.75K | 368.95K | 601.33K | 613.60K | 598.38K | 367.39K |
| Goldman Sachs Group | — | — | — | — | — | — | 46.11K | 166.94K | 59.47K | 182.25K | 737.03K | 671.88K | 439.10K | 226.78K |
| Two Sigma Investments | — | — | — | — | — | — | — | 60.91K | 12.68K | 38.34K | 220.30K | 271.23K | 405.81K | 207.58K |
| Morgan Stanley | 1.37M | 1.00M | — | — | — | 1.42M | 1.46M | 1.56M | 1.54M | 1.52M | 146.27K | 166.49K | 98.87K | 186.05K |
| Charles Schwab Investment Management | — | — | — | — | — | 77.41K | 77.41K | 77.41K | 66.34K | 77.49K | 179.81K | 148.64K | 176.85K | 154.63K |
| Northern Trust Corp | — | — | — | — | — | 140.07K | 144.25K | 145.84K | 142.46K | 136.50K | 137.70K | 129.02K | 134.57K | 146.38K |
| Renaissance Technologies | — | — | — | — | — | 144.95K | 141.95K | 299.71K | 201.15K | 236.45K | 474.21K | 539.01K | 338.44K | 145.85K |
| AQR Capital Management | — | — | — | — | — | — | — | — | 10.63K | 10.04K | 56.60K | 109.74K | 91.01K | 124.80K |
| Bank of America Corp | 215.00K | — | — | 10.00K | — | 16.91K | 28.65K | 32.17K | 132.44K | 187.62K | 75.48K | 116.95K | 144.13K | 123.51K |
| Franklin Resources | — | — | — | — | — | — | 12.77K | 21.81K | 24.24K | 24.37K | 36.59K | 41.02K | 113.88K | 123.36K |
| UBS Group AG | 13.00K | 13.00K | 13.00K | 11.00K | — | — | 9.18K | 13.67K | 46.72K | 68.06K | 100.60K | 46.44K | 50.08K | 122.95K |
| BNY Mellon | — | — | — | — | — | 59.50K | 45.52K | 50.20K | 49.57K | 93.03K | 97.86K | 108.27K | 99.92K | 108.21K |
| Fidelity Management & Research (FMR) | — | — | — | — | — | 21.92K | 48.10K | 10.05K | 10.61K | 3.39K | 59.09K | 67.84K | 79.97K | 96.11K |
| Millennium Management | — | — | — | — | — | 42.47K | — | 70.43K | — | 31.26K | 105.30K | 431.46K | 264.41K | 93.69K |
| Wells Fargo & Co | — | — | — | — | 17.00K | 6.04K | 5.96K | 8.60K | 8.80K | 98.84K | 60.83K | 62.00K | 47.13K | 54.49K |
| Principal Global Investors | — | — | — | — | — | — | — | — | — | 15.99K | 14.36K | 20.80K | 48.65K | 51.95K |
| Wellington Management Group | 3.43M | 4.04M | 4.27M | 4.12M | 1.67M | — | — | 34.98K | 61.40K | 63.82K | 61.77K | 57.00K | 56.50K | 50.86K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details